-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Drotaverine is a widely used pharmaceutical drug that is primarily used to treat urinary tract disorders, such as urinary retention and chronic pelvic pain.
In the chemical industry, Drotaverine is often referred to as an intermediate or a building block for the production of other pharmaceutical drugs.
Upstream Products
The upstream products of Drotaverine refer to the raw materials and starting materials that are used in the production of the drug.
One of the key upstream products for Drotaverine is tamsulosin, which is a selective alpha-adrenergic receptor agonist that is also used to treat urinary tract disorders.
Tamsulosin is converted into Drotaverine through a series of chemical reactions, including hydrogenation, sulfonation, and nitration.
Another important upstream product for Drotaverine is hydrochloric acid, which is used in the hydrolysis of the tamsulosin molecule to produce the necessary starting materials for the synthesis of Drotaverine.
Hydrochloric acid is also used in the purification of the final product, as it is a strong acid that can effectively remove any impurities that may be present.
Downstream Products
The downstream products of Drotaverine refer to the various pharmaceutical drugs and products that are derived from the drug.
One of the most commonly used downstream products of Drotaverine is its combination with the antibiotic cefalyxin, which is used to treat urinary tract infections.
This combination therapy is thought to be more effective than either drug alone, as it attacks the bacteria from two different angles.
Another downstream product of Drotaverine is its use in the production of a medicated urethral catheter.
This catheter is coated with a layer of Drotaverine, which helps to prevent bacterial adhesion and thus reduce the risk of urinary tract infections.
In addition to these downstream products, Drotaverine is also used in the production of other pharmaceutical drugs that are used to treat a variety of conditions, including benign prostatic hyperplasia, erectile dysfunction, and gastroesophageal reflux disease.
Chemical Synthesis
The chemical synthesis of Drotaverine involves a number of steps, including the preparation of the starting materials, the actual synthesis of the drug, and the purification and isolation of the final product.
The synthesis of Drotaverine typically involves the use of chemical reactions such as hydrogenation, sulfonation, and nitration, which are used to modify the tamsulosin molecule and create the necessary structure for the drug.
The actual synthesis of Drotaverine typically involves a series of steps, including the preparation of the starting materials, the addition of different reagents and catalysts, and the purification and isolation of the final product.
The entire process is carefully monitored to ensure that the product meets all of the necessary quality and purity standards.
Quality Control and Regulatory Compliance
In order to ensure that Drotaverine is safe and effective for use in humans, the manufacturing process must adhere to strict quality control standards and regulatory guidelines.
This includes the use of high-quality starting materials, the proper synthesis and purification of the drug, and the thorough testing of the final product to ensure that it meets all of the necessary quality and safety standards.
The production of Drotaverine is also subject to strict regulatory oversight by agencies such as the Food and Drug Administration (FDA) and the European Medicines Agency (EMA).
Manufacturers must comply with a variety of regulations, including good manufacturing practices (GMP) and good laboratory practices (GLP), in order to ensure that the drug is safe and effective for use in humans.
Economic Implications
The production of Drotaverine and its